These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunotherapy offers a promising bet against brain cancer. Eisenstein M Nature; 2018 Sep; 561(7724):S42-S44. PubMed ID: 30258155 [No Abstract] [Full Text] [Related]
4. Cancer vaccines: an update. Hipp JD; Hipp JA; Lyday BW; Minev BR In Vivo; 2000; 14(5):571-85. PubMed ID: 11125541 [TBL] [Abstract][Full Text] [Related]
5. Vaccine strategies for glioblastoma: progress and future directions. Jackson C; Ruzevick J; Brem H; Lim M Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for gastrointestinal malignancies. Toomey PG; Vohra NA; Ghansah T; Sarnaik AA; Pilon-Thomas SA Cancer Control; 2013 Jan; 20(1):32-42. PubMed ID: 23302905 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for pancreatic cancer: current concepts. Kaufman HL; Di Vito J; Hörig H Hematol Oncol Clin North Am; 2002 Feb; 16(1):159-97, viii. PubMed ID: 12063825 [TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen transgenic mouse models for immunotherapy and development of cancer vaccines. Bhattacharya-Chatterjee M; Saha A; Foon KA; Chatterjee SK Curr Protoc Immunol; 2008 Feb; Chapter 20():20.8.1-20.8.12. PubMed ID: 18432635 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of metastasis. Dallal RM; Lotze MT Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596 [TBL] [Abstract][Full Text] [Related]
15. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas. Ueda Y; Itoh T; Nukaya I; Kawashima I; Okugawa K; Yano Y; Yamamoto Y; Naitoh K; Shimizu K; Imura K; Fuji N; Fujiwara H; Ochiai T; Itoi H; Sonoyama T; Hagiwara A; Takesako K; Yamagishi H Int J Oncol; 2004 Apr; 24(4):909-17. PubMed ID: 15010829 [TBL] [Abstract][Full Text] [Related]
16. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications. Wang DK; Zuo Q; He QY; Li B Front Immunol; 2021; 12():705999. PubMed ID: 34447376 [TBL] [Abstract][Full Text] [Related]
18. [The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases]. Alfaro C; Murillo O; Tirapu I; Azpilicueta A; Huarte E; Arina A; Arribillaga L; Pérez-Gracia JL; Bendandi M; Prieto J; Lasarte JJ; Melero I An Sist Sanit Navar; 2006; 29(1):77-96. PubMed ID: 16670731 [TBL] [Abstract][Full Text] [Related]
19. Potential role of tumor vaccines in GI malignancies. Laheru DA; Jaffee EM Oncology (Williston Park); 2000 Feb; 14(2):245-56; discussion 259-60, 265. PubMed ID: 10736811 [TBL] [Abstract][Full Text] [Related]